Mayur Ian Somaiya
Chief Financial Officer · 1 filing · Latest: Jan 20, 2026
NewAmsterdam Pharma Co N.V.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
NAMS | Mayur Ian Somaiya | Chief Financial Officer | Jan 21, 2026 | Sale | $33.59 | 39,784 | $1.3M | 58,382 | |
NAMS | Mayur Ian Somaiya | Chief Financial Officer | Jan 21, 2026 | Option Exercise | $9.26 | 39,784 | $368.4K | 98,166 | |
NAMS | Mayur Ian Somaiya | Chief Financial Officer | Jan 20, 2026 | Sale | $31.96 | 60,216 | $1.9M | 58,382 | |
NAMS | Mayur Ian Somaiya | Chief Financial Officer | Jan 20, 2026 | Option Exercise | $9.26 | 60,216 | $557.6K | 118,598 | |
NAMS | Mayur Somaiya | — | Jan 20, 2026 | Proposed Sale | $31.65 | 200,000 | $6.3M | — | |
NAMS | Mayur Ian Somaiya | — | Jan 5, 2026 | Proposed Sale | $33.25 | 5,118 | $170.2K | — | |
NAMS | Mayur Somalya | — | Jan 27, 2025 | Proposed Sale | $23.20 | 200,000 | $4.6M | — |